Neuregulin1 (NRG1) Signaling through Fyn Modulates NMDA Receptor Phosphorylation: Differential Synaptic Function in NRG1+/− Knock-Outs Compared with Wild-Type Mice

We previously identified Neuregulin1 (NRG1) as a gene contributing to the risk of developing schizophrenia. Furthermore, we showed that NRG1+/− mutant mice display behavioral abnormalities that are reversed by clozapine, an atypical antipsychotic drug used for the treatment of schizophrenia. We now present evidence that ErbB4 (v-erb-a erythroblastic leukemia viral oncogene homolog 4), the tyrosine kinase receptor for NRG1 in hippocampal neurons, interacts with two nonreceptor tyrosine kinases, Fyn and Pyk2 (proline-rich tyrosine kinase 2). NRG1 stimulation of cells expressing ErbB4 and Fyn leads to the association of Fyn with ErbB4 and consequent activation. Furthermore, we show that NRG1 signaling, through activation of Fyn and Pyk2 kinases, stimulates phosphorylation of Y1472 on the NR2B subunit of the NMDA receptor (NMDAR), a key regulatory site that modulates channel properties. NR2B Y1472 is hypophosphorylated in NRG1+/− mutant mice, and this defect can be reversed by clozapine at a dose that reverses their behavioral abnormalities. We also demonstrate that short-term synaptic plasticity is altered and theta-burst long-term potentiation is impaired in NRG1+/− mutant mice, and incubation of hippocampal slices from these mice with NRG1 reversed those effects. Attenuated NRG1 signaling through ErbB4 may contribute to the pathophysiology of schizophrenia through dysfunction of NMDAR modulation. Thus, our data support the glutamate hypothesis of schizophrenia.

[1]  M. Pozza,et al.  Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study , 2003, Neuroscience.

[2]  Paul J. Harrison,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Genes for Schizophrenia? Recent Findings and Their Pathophysiological Implications , 2022 .

[3]  S. Komai,et al.  Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. , 2001, The Journal of biological chemistry.

[4]  M. Behrens,et al.  Metabotropic Glutamate Receptor 1-Induced Upregulation of NMDA Receptor Current: Mediation through the Pyk2/Src-Family Kinase Pathway in Cortical Neurons , 2002, The Journal of Neuroscience.

[5]  J. Buxbaum,et al.  Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia , 2004, Nature Neuroscience.

[6]  Michael W. Salter,et al.  Src kinases: a hub for NMDA receptor regulation , 2004, Nature Reviews Neuroscience.

[7]  D. Yang,et al.  Regulation of Neuregulin Signaling by PSD-95 Interacting with ErbB4 at CNS Synapses , 2000, Neuron.

[8]  D. Goff,et al.  Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia , 2003, Annals of the New York Academy of Sciences.

[9]  M. Sheng,et al.  Role of NMDA Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity , 2004, Science.

[10]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[11]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[12]  Angus C. Nairn,et al.  NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling , 2003, Nature Neuroscience.

[13]  P. Sham,et al.  Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Nakanishi,et al.  PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R Hashimoto,et al.  Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia , 2004, Molecular Psychiatry.

[16]  S. Roysommuti,et al.  Neuregulin-1β modulates in vivo entorhinal–hippocampal synaptic transmission in adult rats , 2003, Neuroscience.

[17]  R. Gerlai,et al.  Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks , 2000, Behavioural Brain Research.

[18]  Didier Cros,et al.  Neuregulin 1–erbB Signaling Is Necessary for Normal Myelination and Sensory Function , 2006, The Journal of Neuroscience.

[19]  Michael Sasner,et al.  Neuregulin-β induces expression of an NMDA-receptor subunit , 1997, Nature.

[20]  Shoji Komai,et al.  Characterization of Fyn-mediated Tyrosine Phosphorylation Sites on GluRε2 (NR2B) Subunit of theN-Methyl-d-aspartate Receptor* , 2001, The Journal of Biological Chemistry.

[21]  D. Henze,et al.  Clozapine Potentiation of N-Methyl-d-aspartate Receptor Currents in the Nucleus Accumbens: Role of NR2B and Protein Kinase A/Src Kinases , 2005, Journal of Pharmacology and Experimental Therapeutics.

[22]  Stephan Heckers,et al.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. , 2003, Pharmacology & therapeutics.

[23]  Xian-Min Yu,et al.  NMDA Channel Regulation by Channel-Associated Protein Tyrosine Kinase Src , 1997, Science.

[24]  D. Allen,et al.  Protein kinase C epsilon signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS. , 2002, Molecular & cellular proteomics : MCP.

[25]  C. Aston,et al.  Microarray analysis of postmortem temporal cortex from patients with schizophrenia , 2004, Journal of neuroscience research.

[26]  Yu Tian Wang,et al.  Regulation of NMDA receptors by tyrosine kinases and phosphatases , 1994, Nature.

[27]  S. Grant,et al.  Proteomic analysis of NMDA receptor–adhesion protein signaling complexes , 2000, Nature Neuroscience.

[28]  Bita Moghaddam,et al.  Bringing Order to the Glutamate Chaos in Schizophrenia , 2003, Neuron.

[29]  Susumu Tonegawa,et al.  Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Fischbach,et al.  Neuregulin and ErbB receptor signaling pathways in the nervous system , 2001, Current Opinion in Neurobiology.

[31]  E. Kandel,et al.  Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. , 1992, Science.

[32]  Y. L. Chen,et al.  [Focal adhesion kinase]. , 1999, Sheng li ke xue jin zhan [Progress in physiology].

[33]  P Ferrara,et al.  In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. , 1992, Analytical biochemistry.

[34]  P. Lombroso,et al.  Striatal Enriched Phosphatase 61 Dephosphorylates Fyn at Phosphotyrosine 420* , 2002, The Journal of Biological Chemistry.

[35]  W. Regehr,et al.  Short-term synaptic plasticity. , 2002, Annual review of physiology.

[36]  Rand Askalan,et al.  Tyrosine Phosphatase STEP Is a Tonic Brake on Induction of Long-Term Potentiation , 2002, Neuron.

[37]  J. Lieberman,et al.  Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs , 2005, Molecular Psychiatry.

[38]  G. Kirov,et al.  Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[39]  Paul J. Harrison,et al.  Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Ying-Chen Yang,et al.  Focal Adhesion Kinase Is Required, But Not Sufficient, for the Induction of Long-Term Potentiation in Dentate Gyrus Neurons In Vivo , 2003, The Journal of Neuroscience.

[41]  A. Buonanno,et al.  The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[42]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Sullivan,et al.  Mechanism of Cannabinoid Effects on Long-Term Potentiation and Depression in Hippocampal CA1 Neurons , 1999, The Journal of Neuroscience.

[44]  G. Frantz,et al.  ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. , 1997, Development.

[45]  Zhen Yan,et al.  Regulation of NMDA Receptors by Neuregulin Signaling in Prefrontal Cortex , 2005, The Journal of Neuroscience.

[46]  D. Hoffman,et al.  Neuregulin-1 Reverses Long-Term Potentiation at CA1 Hippocampal Synapses , 2005, The Journal of Neuroscience.

[47]  E R Kandel,et al.  Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  K. Jardemark,et al.  Calcium/calmodulin‐dependent kinase II is involved in the facilitating effect of clozapine on NMDA‐ and electrically evoked responses in the medial prefrontal cortical pyramidal cells , 2003, Synapse.

[49]  Douglas L Falls,et al.  Neuregulins: functions, forms, and signaling strategies. , 2003, Experimental cell research.

[50]  J. Roder,et al.  CAKβ/Pyk2 Kinase Is a Signaling Link for Induction of Long-Term Potentiation in CA1 Hippocampus , 2001, Neuron.

[51]  John Calvin Reed,et al.  Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. , 1993, Cancer research.

[52]  S. Lev,et al.  A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation , 1996, Nature.